Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma
Narayanan Sadagopan, Aiwu Ruth He
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1259-1259
Open Access | Times Cited: 18

Showing 18 citing articles:

RNA nanotherapeutics for hepatocellular carcinoma treatment
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5
Ethanol inhibits the growth and metastasis of hepatocellular carcinoma by inducing immunogenic cell death
Yu-Chen Hsu, Meng-Chuan Wu, Meng‐Tzu Weng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010472-e010472
Open Access
USP37 as a novel regulator of NRF2 protein stability and chemoresistance in HCC
Shujiao Zhang, Feihu Ding, Fuxin Jia, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma
LI Ji-pin, Yong Tao, Yali Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The molecular characteristics of DNA damage and repair related to P53 mutation for predicting the recurrence and immunotherapy response in hepatocellular carcinoma
Jiayao Ma, Diya Tang, Guangzu Cui, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The IL-12/IL-23 Cytokine Family
Maria Alejandra Clavijo-Salomon, Giorgio Trinchieri, Vito Pistoia
Elsevier eBooks (2025)
Closed Access
Prognostic nutritional index predicts survival in intermediate and advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with PD-(L)1 inhibitors and molecular targeted therapies
Hao-Huan Tang, Mingqing Zhang, Zi-Chen Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Reduction in Liver Cancer Risk by Quercetin via Modulation of Urate Levels: Insights from Drug-Target Mendelian Randomization
Zhengwen Li, Yue Wang, Kai Yang, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 449-449
Open Access
Dihydroartemisinin alleviates diethylnitrosamine-induced hepatocarcinogenesis by targeting a novel MAZ/TRIM50 axis
Ruyuan Liu, Yuanyuan Huang, Di Li, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114733-114733
Closed Access
Strategies to enhance the response of liver cancer to pharmacological treatments
José J.G. Marı́n, Rocı́o I.R. Macı́as, Maitane Asensio, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C11-C33
Closed Access | Times Cited: 2
Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma
A García, Stephen O. Mathew
Cancers (2024) Vol. 16, Iss. 13, pp. 2446-2446
Open Access | Times Cited: 2
ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway
Yixuan Wu, Hongyi Bao, Jinran Wu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Graphene Oxide Nanoparticles for Photothermal Treatment of Hepatocellular Carcinoma Using Low-Intensity Femtosecond Laser Irradiation
Charilaos Xenodochidis, Kamelia Hristova‐Panusheva, Trayana Kamenska, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5650-5650
Open Access | Times Cited: 1
Identification and Validation of Basement Membrane Related LncRNA Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma
Xuyang Liu, Chao Lv, Jian Zheng, et al.
Biochemical Genetics (2024)
Open Access
Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era
Ugo Testa
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 9, pp. 803-827
Open Access
Unveiling EFNB2 as a Key Player in Sorafenib Resistance: Insights from Bioinformatics Analysis and Functional Validation in Hepatocellular Carcinoma
Junli Pan, Quanxi Li, Junli Zhu
Biochemical Genetics (2024)
Closed Access
m6A and beyond: RNA modifications shaping angiogenesis
Yu Luan, Renbing Jia, Peiwei Chai, et al.
Trends in Molecular Medicine (2024)
Closed Access
Construction and Validation of a Novel Model for Guiding Targeted Combined Immunotherapy in Advanced Hepatocellular Carcinoma
Haibin Tu, Siyi Feng, Lihong Chen, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top